Forte Biosciences, Inc. (FBRX) Weighted Average Number of Shares Outstanding, Diluted 2021 - 2023

Historical data

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Forte Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2023.
  • Forte Biosciences, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2023 was 21 M shares, a 42.6% increase year-over-year.
  • Forte Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 17.4 M shares, a 24.5% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 21 M +6.29 M +42.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 21 M +6.25 M +42.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 17.4 M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 18.9 M +4.69 M +32.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 14.8 M +1.16 M +8.51% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 14.8 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 14.2 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 13.6 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.